Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07463118) titled 'Game-Based Intervention to Reduce Alcohol Use Among Youth' on March 2. Study... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07463222) titled 'Neuroendocrine Response in Pediatric Febrile Seizures' on March 2. Study Typ... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07460596) titled 'Concentrated Complex Plant Dietary Elements for Chemotherapy-Induced Diarrhea... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07462585) titled 'Impact of the Model Health Behaviour Mother 1000 Days of Life Health Online-B... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07461935) titled 'ALPs Single ChambEr New Device' on March 2. Study Type: Interventional Stu... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07463053) titled 'Mass Balance and Absolute Bioavailability Study of JMKX003142 In Healthy Volu... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119631) titled 'Study on the efficacy and safety of AP regimen in the chronotherapy of a... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119636) titled 'Clinical Efficacy of Ablation of Slow Conduction and Low-Voltage Myocard... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119639) titled 'Open-label, randomized, phase II clinical study of camrelizumab combined... Read More
Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119645) titled 'A randomised phase II study of limertinib and bevacizumab versus limerti... Read More